PSK (polysaccharide-K)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PSK (polysaccharide-K), covering 2016-06-07 to 2016-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK [Phase 3]